Analgesics
Antiandrogens
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Abstract
All iota‑carrageenan studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19early.org COVID-19 treatment researchIota-carrageenanIota-carragee.. (more..)
Melatonin Meta
Metformin Meta
Azvudine Meta
Bromhexine Meta Molnupiravir Meta
Budesonide Meta
Colchicine Meta
Conv. Plasma Meta Nigella Sativa Meta
Curcumin Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   

Iota-carrageenan prevents the replication of SARS-CoV-2 on an in vitro respiratory epithelium model

Varese et al., bioRxiv, doi:10.1101/2021.04.27.441512
Apr 2021  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
In Vitro Calu-3 (human respiratory epithelial cell line) study showing that iota-carrageenan inhibits SARS-CoV-2.
15 preclinical studies support the efficacy of iota-carrageenan for COVID-19:
Varese et al., 27 Apr 2021, preprint, 5 authors.
In Vitro studies are an important part of preclinical research, however results may be very different in vivo.
This PaperIota-carragee..All
Iota-carrageenan prevents the replication of SARS-CoV-2 on an in vitro respiratory epithelium model
Augusto Varese, Ana Ceballos, Carlos Palacios, Juan Manuel Figueroa, Andrea Vanesa Dugour
doi:10.1101/2021.04.27.441512
There are, except for remdesivir, no approved antivirals for the treatment or prevention of SARS-CoV-2 infections. Iota-carrageenan formulated into a nasal spray has already been proven safe and effective in viral respiratory infections. We explored this antiviral activity in Calu-3, a human respiratory model cell line. A formula of iota-carrageenan and sodium chloride, as a nasal spray, already approved for human use, effectively inhibited SARS-CoV-2 infection in vitro, providing a more substantial reference for further clinical studies or developments.
Conflict of Interest The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. Author Contributions AC, AVD, and JMF conceptualized the study. AC, AV, CP and AVD developed the methodology. JMF wrote and prepared the original draft. AC, AVD, and CP wrote, reviewed, and edited the manuscript. AC and AVD supervised the study. All authors contributed to the article and approved the submitted version.
References
Banerjee, Nasir, Budylowski, Yip, Aftanas et al., Isolation, Sequence, Infectivity, and Replication Kinetics of Severe Acute Respiratory Syndrome Coronavirus 2, Emerg Infect Dis, doi:10.3201/eid2609.201495
Bansal, Jonsson, Taylor, Figueroa, Dugour et al., Iota-carrageenan and Xylitol inhibit SARS-CoV-2 in cell culture, Biorxiv, doi:10.1101/2020.08.19.225854
Barrett, Terpening, Snow, Cobb, Kistner, Vero cell technology for rapid development of inactivated whole virus vaccines for emerging viral diseases, Expert Rev Vaccines, doi:10.1080/14760584.2017.1357471
Chen, Han, Wang, Zhao, Application prospect of polysaccharides in the development of anti-novel coronavirus drugs and vaccines, Int J Biol Macromol, doi:10.1016/j.ijbiomac.2020.07.106
Dong, Du, Gardner, An interactive web-based dashboard to track COVID-19 in real time, Lancet Infect Dis, doi:10.1016/s1473-3099(20)30120-1
Duszyk, CFTR and lysozyme secretion in human airway epithelial cells, Pflügers Archiv, doi:10.1007/s004240100643
Felgenhauer, Schoen, Gad, Hartmann, Schaubmar et al., Inhibition of SARS-CoV-2 by type I and type III interferons, J Biol Chem, doi:10.1074/jbc.ac120.013788
Figueroa, Lombardo, Dogliotti, Flynn, Giugliano et al., Efficacy of a nasal spray containing Iota-Carrageenan in the prophylaxis of COVID-19 in hospital personnel dedicated to patients care with COVID-19 disease A pragmatic multicenter, randomized, double-blind, placebo-controlled trial, CARR-COV, doi:10.1101/2021.04.13.21255409
Gomaa, Elshoubaky, Antiviral Activity of Sulfated Polysaccharides Carrageenan from Some Marine Seaweeds, International Journal of Current Pharmaceutical Review and Research
Grassauer, Weinmuellner, Meier, Pretsch, Prieschl-Grassauer et al., Iota-Carrageenan is a potent inhibitor of rhinovirus infection, Virol J, doi:10.1186/1743-422x-5-107
Gubernatorova, Gorshkova, Polinova, Drutskaya, IL-6: relevance for immunopathology of SARS-CoV-2, Cytokine Growth F R, doi:10.1016/j.cytogfr.2020.05.009
Hans, Malik, Naik, Antiviral activity of sulfated polysaccharides from marine algae and its application in combating COVID-19: Mini review, Bioresour Technology Reports, doi:10.1016/j.biteb.2020.100623
Hoffmann, Mösbauer, Hofmann-Winkler, Kaul, Kleine-Weber et al., Chloroquine does not inhibit infection of human lung cells with SARS-CoV-2, Nature, doi:10.1038/s41586-020-2575-3
Holwerda, V'kovski, Wider, Thiel, Dijkman, Identification of an Antiviral Compound from the Pandemic Response Box that Efficiently Inhibits SARS-CoV-2
Koenighofer, Lion, Bodenteich, Prieschl-Grassauer, Grassauer et al., Carrageenan nasal spray in virus confirmed common cold: individual patient data analysis of two randomized controlled trials, Multidiscip Resp Med, doi:10.1186/2049-6958-9-57
Leibbrandt, Meier, König-Schuster, Weinmüllner, Kalthoff et al., Iota-Carrageenan Is a Potent Inhibitor of Influenza A Virus Infection, Plos One, doi:10.1371/journal.pone.0014320
Morokutti-Kurz, Graf, Grassauer, Prieschl-Grassauer, SARS-CoV-2 invitro neutralization assay reveals inhibition of virus entry by iota-carrageenan, Biorxiv, doi:10.1101/2020.07.28.224733
Morokutti-Kurz, König-Schuster, Koller, Graf, Graf et al., The Intranasal Application of Zanamivir and Carrageenan Is Synergistically Active against Influenza A Virus in the Murine Model, Plos One, doi:10.1371/journal.pone.0128794
Murgolo, Therien, Howell, Klein, Koeplinger et al., SARS-CoV-2 tropism, entry, replication, and propagation: Considerations for drug discovery and development, Plos Pathog, doi:10.1371/journal.ppat.1009225
Osada, Kohara, Yamaji, Hirayama, Kasai et al., The Genome Landscape of the African Green Monkey Kidney-Derived Vero Cell Line, Dna Res, doi:10.1093/dnares/dsu029
Park, Kim, Park, Maharjan, Kim et al., Differential Signaling and Virus Production in Calu-3 Cells and Vero Cells upon SARS-CoV-2 Infection, Biomol Ther, doi:10.4062/biomolther.2020.226
Saccon, Chen, Mikaeloff, Rodriguez, Szekely et al., Tropism of SARS-CoV-2 in commonly used laboratory cell lines and their proteomic landscape during infection, Biorxiv, doi:10.1101/2020.08.28.271684
Salgado-Benvindo, Thaler, Tas, Ogando, Bredenbeek et al., Suramin Inhibits SARS-CoV-2 Infection in Cell Culture by Interfering with Early Steps of the Replication Cycle, Antimicrob Agents Ch, doi:10.1128/aac.00900-20
Song, Peng, Wang, Liu, Dong et al., Inhibitory activities of marine sulfated polysaccharides against SARS-CoV-2, Food Funct, doi:10.1039/d0fo02017f
Yamamoto, Kiso, Sakai-Tagawa, Iwatsuki-Horimoto, Imai et al., The Anticoagulant Nafamostat Potently Inhibits SARS-CoV-2 S Protein-Mediated Fusion in a Cell Fusion Assay System and Viral Infection In Vitro in a Cell-Type-Dependent Manner, Viruses, doi:10.3390/v12060629
Zhu, Chidekel, Shaffer, Cultured Human Airway Epithelial Cells (Calu-3): A Model of Human Respiratory Function, Structure, and Inflammatory Responses, Critical Care Res Pract, doi:10.1155/2010/394578
Zhu, Miller, Singhaus, Shaffer, Chidekel, Effects of oxygen concentration and exposure time on cultured human airway epithelial cells, Pediatr Crit Care Me, doi:10.1097/pcc.0b013e318166fbb5
{ 'DOI': '10.1101/2021.04.27.441512', 'URL': 'http://dx.doi.org/10.1101/2021.04.27.441512', 'abstract': '<jats:title>Abstract</jats:title><jats:p>There are, except for remdesivir, no approved ' 'antivirals for the treatment or prevention of SARS-CoV-2 infections. Iota-carrageenan ' 'formulated into a nasal spray has already been proven safe and effective in viral respiratory ' 'infections. We explored this antiviral activity in Calu-3, a human respiratory model cell ' 'line. A formula of iota-carrageenan and sodium chloride, as a nasal spray, already approved ' 'for human use, effectively inhibited SARS-CoV-2 infection in vitro, providing a more ' 'substantial reference for further clinical studies or developments.</jats:p>', 'accepted': {'date-parts': [[2021, 4, 27]]}, 'author': [ { 'ORCID': 'http://orcid.org/0000-0002-3129-2048', 'affiliation': [], 'authenticated-orcid': False, 'family': 'Varese', 'given': 'Augusto', 'sequence': 'first'}, { 'ORCID': 'http://orcid.org/0000-0003-4564-7361', 'affiliation': [], 'authenticated-orcid': False, 'family': 'Ceballos', 'given': 'Ana', 'sequence': 'additional'}, { 'ORCID': 'http://orcid.org/0000-0002-3368-0538', 'affiliation': [], 'authenticated-orcid': False, 'family': 'Palacios', 'given': 'Carlos', 'sequence': 'additional'}, { 'ORCID': 'http://orcid.org/0000-0002-5680-1486', 'affiliation': [], 'authenticated-orcid': False, 'family': 'Figueroa', 'given': 'Juan Manuel', 'sequence': 'additional'}, { 'ORCID': 'http://orcid.org/0000-0002-0187-0548', 'affiliation': [], 'authenticated-orcid': False, 'family': 'Dugour', 'given': 'Andrea Vanesa', 'sequence': 'additional'}], 'container-title': [], 'content-domain': {'crossmark-restriction': False, 'domain': []}, 'created': {'date-parts': [[2021, 4, 27]], 'date-time': '2021-04-27T22:45:33Z', 'timestamp': 1619563533000}, 'deposited': { 'date-parts': [[2022, 5, 25]], 'date-time': '2022-05-25T19:49:05Z', 'timestamp': 1653508145000}, 'group-title': 'Microbiology', 'indexed': {'date-parts': [[2024, 3, 1]], 'date-time': '2024-03-01T23:48:20Z', 'timestamp': 1709336900933}, 'institution': [{'name': 'bioRxiv'}], 'is-referenced-by-count': 2, 'issued': {'date-parts': [[2021, 4, 27]]}, 'link': [ { 'URL': 'https://syndication.highwire.org/content/doi/10.1101/2021.04.27.441512', 'content-type': 'unspecified', 'content-version': 'vor', 'intended-application': 'similarity-checking'}], 'member': '246', 'original-title': [], 'posted': {'date-parts': [[2021, 4, 27]]}, 'prefix': '10.1101', 'published': {'date-parts': [[2021, 4, 27]]}, 'publisher': 'Cold Spring Harbor Laboratory', 'reference': [ { 'DOI': '10.3201/eid2609.201495', 'doi-asserted-by': 'publisher', 'key': '2021042904350956000_2021.04.27.441512v1.1'}, { 'DOI': '10.1101/2020.08.19.225854', 'doi-asserted-by': 'publisher', 'key': '2021042904350956000_2021.04.27.441512v1.2'}, { 'DOI': '10.1080/14760584.2017.1357471', 'doi-asserted-by': 'publisher', 'key': '2021042904350956000_2021.04.27.441512v1.3'}, { 'DOI': '10.1016/j.ijbiomac.2020.07.106', 'doi-asserted-by': 'publisher', 'key': '2021042904350956000_2021.04.27.441512v1.4'}, { 'DOI': '10.1016/s1473-3099(20)30120-1', 'doi-asserted-by': 'publisher', 'key': '2021042904350956000_2021.04.27.441512v1.5'}, { 'DOI': '10.1007/s004240100643', 'doi-asserted-by': 'publisher', 'key': '2021042904350956000_2021.04.27.441512v1.6'}, { 'DOI': '10.1074/jbc.ac120.013788', 'doi-asserted-by': 'publisher', 'key': '2021042904350956000_2021.04.27.441512v1.7'}, { 'DOI': '10.1101/2021.04.13.21255409', 'doi-asserted-by': 'publisher', 'key': '2021042904350956000_2021.04.27.441512v1.8'}, { 'article-title': 'Antiviral Activity of Sulfated Polysaccharides Carrageenan from Some ' 'Marine Seaweeds', 'first-page': '32', 'journal-title': 'International Journal of Current Pharmaceutical Review and Research', 'key': '2021042904350956000_2021.04.27.441512v1.9', 'volume': '1', 'year': '2016'}, { 'DOI': '10.1186/1743-422X-5-107', 'doi-asserted-by': 'publisher', 'key': '2021042904350956000_2021.04.27.441512v1.10'}, { 'DOI': '10.1016/j.cytogfr.2020.05.009', 'doi-asserted-by': 'publisher', 'key': '2021042904350956000_2021.04.27.441512v1.11'}, { 'DOI': '10.1016/j.biteb.2020.100623', 'doi-asserted-by': 'publisher', 'key': '2021042904350956000_2021.04.27.441512v1.12'}, { 'DOI': '10.1038/s41586-020-2575-3', 'doi-asserted-by': 'publisher', 'key': '2021042904350956000_2021.04.27.441512v1.13'}, { 'DOI': '10.3390/microorganisms8121872', 'doi-asserted-by': 'publisher', 'key': '2021042904350956000_2021.04.27.441512v1.14'}, { 'DOI': '10.1186/2049-6958-9-57', 'doi-asserted-by': 'publisher', 'key': '2021042904350956000_2021.04.27.441512v1.15'}, { 'DOI': '10.1371/journal.pone.0014320', 'doi-asserted-by': 'publisher', 'key': '2021042904350956000_2021.04.27.441512v1.16'}, { 'DOI': '10.1101/2020.07.28.224733', 'doi-asserted-by': 'publisher', 'key': '2021042904350956000_2021.04.27.441512v1.17'}, { 'DOI': '10.1371/journal.pone.0128794', 'doi-asserted-by': 'publisher', 'key': '2021042904350956000_2021.04.27.441512v1.18'}, { 'DOI': '10.1371/journal.ppat.1009225', 'doi-asserted-by': 'publisher', 'key': '2021042904350956000_2021.04.27.441512v1.19'}, { 'DOI': '10.1093/dnares/dsu029', 'doi-asserted-by': 'publisher', 'key': '2021042904350956000_2021.04.27.441512v1.20'}, { 'DOI': '10.4062/biomolther.2020.226', 'doi-asserted-by': 'publisher', 'key': '2021042904350956000_2021.04.27.441512v1.21'}, { 'DOI': '10.1101/2020.08.28.271684', 'doi-asserted-by': 'publisher', 'key': '2021042904350956000_2021.04.27.441512v1.22'}, { 'DOI': '10.1128/aac.00900-20', 'doi-asserted-by': 'publisher', 'key': '2021042904350956000_2021.04.27.441512v1.23'}, { 'DOI': '10.1039/d0fo02017f', 'doi-asserted-by': 'publisher', 'key': '2021042904350956000_2021.04.27.441512v1.24'}, { 'DOI': '10.3390/v12060629', 'doi-asserted-by': 'publisher', 'key': '2021042904350956000_2021.04.27.441512v1.25'}, { 'DOI': '10.1155/2010/394578', 'doi-asserted-by': 'publisher', 'key': '2021042904350956000_2021.04.27.441512v1.26'}, { 'DOI': '10.1097/pcc.0b013e318166fbb5', 'doi-asserted-by': 'publisher', 'key': '2021042904350956000_2021.04.27.441512v1.27'}], 'reference-count': 27, 'references-count': 27, 'relation': { 'is-preprint-of': [ { 'asserted-by': 'subject', 'id': '10.3389/fviro.2021.746824', 'id-type': 'doi'}]}, 'resource': {'primary': {'URL': 'http://biorxiv.org/lookup/doi/10.1101/2021.04.27.441512'}}, 'score': 1, 'short-title': [], 'source': 'Crossref', 'subject': [], 'subtitle': [], 'subtype': 'preprint', 'title': 'Iota-carrageenan prevents the replication of SARS-CoV-2 on an in vitro respiratory epithelium ' 'model', 'type': 'posted-content'}
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit